http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12706538

Outgoing Links

Predicate Object
contentType Journal Article
issn 2044-5040
issueIdentifier 1
pageRange 8-
publicationName Skeletal Muscle
startingPage 8
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40bccd05842e3d795ddac5edd349a772
bibliographicCitation Goyenvalle A, Davies KE. Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy. Skelet Muscle. 2011 Feb 09;1(1):8. PMID: 21798085; PMCID: PMC3156649.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_713a2144e1554137915a4c34d60bcf6b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc9dc7512642ee1ee3659b7e981b1c94
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3938-1165
date 2011-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21798085
https://pubmed.ncbi.nlm.nih.gov/PMC3156649
https://doi.org/10.1186/2044-5040-1-8
isPartOf https://portal.issn.org/resource/ISSN/2044-5040
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39284
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133899
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8544
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10573

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129819312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128080983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128920222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127452483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127657812

Total number of triples: 31.